» Articles » PMID: 27363996

Bone Microarchitecture Deteriorations and A fragility Fracture in A patient with Beta and Alpha Heterozygous Thalassemia: A case Report

Overview
Publisher Springer
Specialty General Medicine
Date 2016 Jul 2
PMID 27363996
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

To date there are few studies that have investigated bone mineral density (BMD) and markers of bone metabolism in patients with thalassemia minor form. None of the previous trials presented bone structure analysis in the patient populations. We present the case of a 24-year-old Turkish woman with heterozygous beta and alpha thalassemia who sustained a low-trauma fracture of the inferior pubic ramus. Despite normal markers of bone metabolism, the dual X‑ray absorptiometry (DXA) showed decreased areal bone mineral density. Furthermore, severely reduced bone structure parameters and reduced volumetric bone mineral density was assessed by high-resolution peripheral quantitative computed tomography (HR-pQCT). Due to these diagnostic findings at time of peak bone mass, an osteoanabolic therapy with teriparatide for 24 months was initiated. The findings concerning BMD and bone structure in this patient can be seen as caused by the beta and alpha thalassemia.

Citing Articles

The comparability of HR-pQCT bone measurements is improved by scanning anatomically standardized regions.

Bonaretti S, Majumdar S, Lang T, Khosla S, Burghardt A Osteoporos Int. 2017; 28(7):2115-2128.

PMID: 28391447 PMC: 5526099. DOI: 10.1007/s00198-017-4010-7.

References
1.
Kocijan R, Muschitz C, Haschka J, Hans D, Nia A, Geroldinger A . Bone structure assessed by HR-pQCT, TBS and DXL in adult patients with different types of osteogenesis imperfecta. Osteoporos Int. 2015; 26(10):2431-40. DOI: 10.1007/s00198-015-3156-4. View

2.
Saki N, Abroun S, Salari F, Rahim F, Shahjahani M, Javad M . Molecular Aspects of Bone Resorption in β-Thalassemia Major. Cell J. 2015; 17(2):193-200. PMC: 4503833. DOI: 10.22074/cellj.2016.3713. View

3.
Taher A, Musallam K, Cappellini M, Weatherall D . Optimal management of β thalassaemia intermedia. Br J Haematol. 2011; 152(5):512-23. DOI: 10.1111/j.1365-2141.2010.08486.x. View

4.
Kalef-Ezra J, Challa A, Chaliasos N, Hatzikonstantinou I, Papaefstathiou I, Cholevas V . Bone minerals in beta-thalassemia minor. Bone. 1995; 16(6):651-5. DOI: 10.1016/8756-3282(95)00117-v. View

5.
Wong P, Fuller P, Gillespie M, Kartsogiannis V, Kerr P, Doery J . Thalassemia bone disease: a 19-year longitudinal analysis. J Bone Miner Res. 2014; 29(11):2468-73. DOI: 10.1002/jbmr.2266. View